AVNT AVIENT CORP
Plastic Materials, Synth Resins & Nonvulcan Elastomers · NYSE · SEC CIK 1122976 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.2%
TTM net income YoY59.0%
TTM EPS YoY58.5%
Revenue 3-yr CAGR2.1%
Net income 3-yr CAGR-32.7%
Margins
Gross margin31.7%
Operating margin9.7%
Net margin5.3%
FCF margin7.0%
EBITDA margin15.3%
Returns
ROE7.5%
ROA3.0%
ROIC (approx.)6.4%
Asset turnover0.57x
Leverage & solvency
Liabilities / assets58.4%
Debt / equity0.74x
Current ratio1.71x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.93x
Accruals ratio-2.8%
Payout ratio55.7%
Capex / revenue3.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.26B | $3.24B | $3.14B | $3.40B | $3.32B |
| Cost of revenue | $2.24B | $2.18B | $2.25B | $2.51B | $2.37B |
| Gross profit | $1.02B | $1.06B | $892.50M | $882.70M | $943.80M |
| R&D expense | $96.70M | $98.70M | $90.30M | $84.90M | $83.20M |
| SG&A expense | $812.10M | $727.40M | $695.70M | $639.40M | $664.10M |
| Operating income | $203.50M | $329.30M | $196.80M | $243.30M | $279.70M |
| Pretax income | $111.70M | $224.80M | $87.30M | $63.80M | $203.50M |
| Income tax | $28.10M | $54.10M | $11.00M | -$19.30M | $51.90M |
| Net income | $81.90M | $169.50M | $75.70M | $703.10M | $230.80M |
| EBITDA | $389.40M | $509.00M | $385.60M | $406.40M | $423.90M |
| EPS (basic) | 0.90 | 1.86 | 0.83 | 7.71 | 2.53 |
| EPS (diluted) | 0.89 | 1.84 | 0.83 | 7.63 | 2.51 |
| Dividends declared per share | 1.08 | 1.04 | 1.00 | 0.96 | 0.88 |
| Weighted avg. shares (diluted) | 91.80M | 92.00M | 91.80M | 92.20M | 92.10M |
| Banking | |||||
| Net interest income | — | — | -$115.30M | -$119.80M | -$75.20M |
| Balance sheet | |||||
| Cash & equivalents | $510.50M | $544.50M | $545.80M | $641.10M | $601.20M |
| Receivables | $435.00M | $399.50M | $399.90M | $440.60M | $439.90M |
| Inventory | $367.20M | $346.80M | $347.00M | $372.70M | $305.80M |
| Current assets | $1.40B | $1.42B | $1.41B | $1.57B | $1.83B |
| PP&E, net | $988.80M | $955.30M | $1.03B | $1.05B | $672.30M |
| Goodwill | $1.76B | $1.66B | $1.72B | $1.67B | $1.28B |
| Intangibles | $1.49B | $1.45B | $1.59B | $1.60B | $925.20M |
| Total assets | $6.03B | $5.81B | $5.97B | $6.08B | $5.00B |
| Current liabilities | $846.30M | $756.10M | $773.60M | $869.40M | $940.60M |
| Short-term debt | $500,000 | $7.70M | $9.50M | $2.20M | $8.60M |
| Long-term debt | $1.92B | $2.06B | $2.07B | $2.18B | $1.85B |
| Total debt | $1.92B | $2.07B | $2.08B | $2.18B | $1.86B |
| Total liabilities | $3.64B | $3.48B | $3.63B | $3.73B | $3.21B |
| Shareholders' equity | $2.37B | $2.31B | $2.32B | $2.33B | $1.77B |
| Net debt | $1.41B | $1.52B | $1.53B | $1.54B | $1.26B |
| Cash flow statement | |||||
| Operating cash flow | $301.60M | $256.80M | $201.60M | $398.40M | $233.80M |
| Capital expenditure | $106.60M | $121.90M | $119.40M | $105.50M | $100.60M |
| Free cash flow | $195.00M | $134.90M | $82.20M | $292.90M | $133.20M |
| Investing cash flow | -$97.00M | -$120.60M | -$94.20M | -$504.00M | -$150.20M |
| Financing cash flow | -$257.10M | -$120.90M | -$201.70M | $166.40M | -$114.60M |
| Depreciation & amortization | $185.90M | $179.70M | $188.80M | $163.10M | $144.20M |
| Stock-based compensation | $9.10M | $15.40M | $13.20M | $13.20M | $11.20M |
| Dividends paid | $98.80M | $94.00M | $90.20M | $86.80M | $77.70M |
| Share buybacks | — | $0 | $0 | $36.40M | $4.20M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.